Luca Valle

15PUBLICATIONS
76CO-AUTHORS
Predictive and prognostic markersRadiation therapyPhotogrammetry and remote sensingCancer therapy (excl. chemotherapy and radiation therapy)Models of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 15, 2026
Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.

|Mar 18, 2026
Reply to: Comments on the LUNAR Trial in Oligorecurrent Hormone-Sensitive Prostate Cancer.

Luca F Valle, Jeremie Calais, Amar U Kishan

|Nov 12, 2025
177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study.

Amar U Kishan, Luca F Valle, Holly Wilhalme

|Apr 07, 2025
Validation and Derivation of miRNA-Based Germline Signatures Predicting Radiation Toxicity in Prostate Cancer.

Amar U Kishan, Kristen McGreevy, Luca Valle

|Jul 16, 2024
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study.

John Nikitas, Kritika Subramanian, Nimrod Barashi Gozal

|Mar 16, 2024
Treatment intensification strategies for men undergoing definitive radiotherapy for high-risk prostate cancer.

John Nikitas, Amar Kishan, Albert Chang

Pageof 3

Frequent Collaborators

6 joint publications

Michael Steinberg

5 joint publications

Amar U Kishan

3 joint publications

Robert Reiter

3 joint publications

Ting Martin Ma